Invention Grant
- Patent Title: Drug combination and its use in the treatment of muscle loss
- Patent Title (中): 药物组合及其在治疗肌肉损失中的应用
-
Application No.: US12594985Application Date: 2008-04-24
-
Publication No.: US08653052B2Publication Date: 2014-02-18
- Inventor: Julian Clive Gilbert , Robert William Gristwood
- Applicant: Julian Clive Gilbert , Robert William Gristwood
- Applicant Address: GB Cambridge
- Assignee: Acacia Pharma Limited
- Current Assignee: Acacia Pharma Limited
- Current Assignee Address: GB Cambridge
- Agency: Saliwanchik, Lloyd & Eisenschenk
- Priority: GB0707930.4 20070424; GB0707931.2 20070424; GB0710101.7 20070525
- International Application: PCT/GB2008/001452 WO 20080424
- International Announcement: WO2008/129308 WO 20081030
- Main IPC: A61K31/56
- IPC: A61K31/56
Abstract:
The present invention is a product comprising a β2 agonist and a progestin, as a combined preparation for separate, simultaneous or sequential use in the treatment or prevention of muscle loss. The present invention is also a β2 agonist selected from R,R-formoterol, indacaterol or ritodrine, for use in the treatment or prevention of muscle loss.
Public/Granted literature
- US20100130456A1 Drug Combination and Its Use in the Treatment of Muscle Loss Public/Granted day:2010-05-27
Information query
